Naslov
Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease

Autori
Kumrić, Marko ; Živković, Piero Marin ; Tičinović Kurir, Tina ; Vrdoljak, Josip ; Vilović, Marino ; Martinović, Dinko ; Bratanić, Andre ; Lizatović, Ivan Krešimir ; Božić, Joško

Izvornik
Diagnostics (2075-4418) 12 (2021), 1; 45, 14

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
B-cell activating factor ; biomarker ; calprotectin ; diagnosis ; inflammatory bowel disease ; irritable bowel syndrome.

Sažetak
As early commencement of inflammatory bowel disease (IBD) treatment has been shown to substantially improve outcomes, it is of utmost importance to make a timely diagnosis of this disease. Despite undisputed sensitivity of fecal calprotectin, the most widely accepted IBD biomarker, in discriminating between irritable bowel syndrome (IBS) and IBD, as well as recognized role in monitoring disease activity and response to therapy, perhaps the biggest setback of calprotectin use in IBD is lack of specificity. Therefore, an additional biomarker in IBD is warranted. B-cell activating factor (BAFF), a member of the tumor necrosis factor (TNF) superfamily, recently emerged as a viable candidate for this role. So far, overproduction of BAFF has been observed in various autoimmune diseases, most notably in systemic lupus erythematosus, where BAFF-inhibitor belimumab was approved for treatment. As BAFF levels were also shown to correlate with indices of IBD, in this review we aimed to summarize the current evidence with respect to the role of BAFF in diagnosis and assessing the activity of IBD, as well as putative therapeutic implications that may arise from exploring of this relation.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA